Introduction
For the past 50 years, many of the halogenated aromatic hydrocarbon compounds have enjoyed worldwide industrial and agricultural utility These compounds have proven to be environmentally stable and highly persistent. Those which are least polar and resist metabolism and excretion readily bioaccumulate. Residues that have been identified in human biological specimens (Table 1) collected worldwide have raised public health concerns (1, 2) .
The most widely disseminated halogenated compounds which have received the most regulatory attention can be divided roughly into those used as pesticides and those with industrial applications: primarily the PCBs. Once the undesirable persistence and migration through soil, water, and into the human food chain was recognized, limiting additional environmental burdens of pesticides was more amenable to regulation and control than the circumstances surrounding PCBs. For pesticides the primary entry into the ecosystem was through the intended application of the product. In the United States and many other countries, these insecticides have either been completely removed from the market or Following the pesticide control model, restricting the manufacture and utilization of PCBs was the initial step toward limiting escape into the environment. However, unlike pesticides, vast quantities of PCBs remain in transformers and other manufactured products still in use and represent latent exposure potential. When these products require disposal, they will pose an additional contamination threat. Already disfunctional and discarded products exist in dumps and refuse sites which are now recognized as being unable to prevent escape of PCB containing leachate or other contaminated materials. Controlling future contamination of procedure requires 20 to 30 min per sample. Observational and interview follow-up on a sample of the PBB exposed individuals found some morbidity, primarily bruising (greater than 5 cm), persistent pain, and discomfort at the biopsy site (longer than 48 hr) in 5 to 10% of the subjects. The PBB studies suggested that females had a greater propensity to develop extensive bruising.
While serial study of the same individual is possible with this technique, subject motivation is crucial for success. Industrial or other high risk groups find the technique more acceptable than control or general population groups.
If a sample greater than 200 mg is needed because of technical-laboratory needs (current dioxin analysis procedures usually request 10-20 g), the alternative is a surgical biopsy. This is a physician's office or hospital procedure most often requiring a follow-up visit for removal of stitches or clips from the biopsy site. Although morbidity has not been quantified, anecdotally it is reported to be similar to that of the needle biopsy with the added occasional permanent "dimple" at the site of tissue removal and the small incision scar. Resistance to serial study is expected to be greater than to the needle biopsy. Utilization of this method has been limited to small, selected high risk groups.
In the absence of overt clinical disease or the investigation of possible poisoning, interpreting the clinical significance of the analytical results is difficult. A result can be placed in descriptive perspective with other "general population" or occupational group values; but assigning a future disease risk is still quite speculative.
Despite these drawbacks, the adipose tissue biopsy remains the reference indicator of exposure tool and does have several distinct advantages over serum, whole blood, or breast milk which are the most commonly utilized biological materials gathered to assess exposure to the halogenated hydrocarbons.
Because of the favorable partitioning ratio (lipid to serum), the high lipid content of adipose tissue allows increased detectability of body burden. For example ( Fig. 1 More dramatic is the decline in nondetectables in the under 15 age group (Fig. 3) . While the number of children with detectable levels has increased, the number with levels above 3 ppm is declining. However, it may be too early to view this trend from 1979 and 1981 data as definitive. Unfortunately, serial samples from the same individual are not possible, and thus any decline in the rate of individual accumulation of PCBs cannot be directly ascertained. Long-term surveys such as this play an important role in our assessment of population dynamics and efforts implemented to decrease exposure to these chemicals, and should be able to provide an indication that the rate of bioaccumulation has decreased or increased. (14) tions has been hindered by the availability ofcomprehensive data sets. The apparent lack of dose response relationships in data sets which include health data and tissue concentration measurements has always been perplexing. Exposure ranges of four orders of magnitude have been described, but human health effects have not distributed consistently in the anticipated manner. The question has been raised whether the current methodology of reporting values accurately reflects toxicologic potential.
PCBs and PBBs are complex mixtures. Convention has determined which peaks relative to a commercial mixture will be quantified to arrive at the composite concentration used to describe the exposure. As discussed at this conference, over 40 PCB congeners have been identified in human adipose tissue, yet they are combined for descriptive purposes. Ibxicologically they are far from identical. Current advances in analytic capability have allowed investigation to begin assessing individual isomers and how they distribute in human tissues.
The PBB contamination episode provided an opportunity to study large populations. Although some early investigations suggested serum and adipose tissue levels did not seem to correlate well with each other, the studies performed after continuing exposures had ceased and equilibration had apparently occurred did find excellent correlation between serum and adipose levels.
PCBs, DDT and DDE are more widely disseminated in the environment than PBBs. Figure 4 displays the scatterplot of the 27 paired serum and adipose tissue samples from the 1976 survey of PBB exposed chemical workers (6) . Both (Table 3) . Wolff et. al. (14) reported three groups of partition ratios for PCB isomers from an occupationally exposed group. The ratios of adipose to serum ranged from about 80:1 to 200:1. The mixture of isomers in the exposure becomes important when interpreting the ratios observed.
Tuey and Matthews (15) have noted the similarity between the human adipose-serum PBB partition to that which is predicted by their pharmacokinetic animal model. Their model predicts PBB equilibrium at 340:1. The differences in the partition ratios reported by the different authors listed in Table 3 (6) (7) (8) (9) (10) (11) (12) (13) (14) may be a function of time since exposure. Experience with DDE and DDT suggest it may take several years for equilibration to have stabilized. Until equilibrium is reached, the ratios would be expected to be lower.
Unless acute, high exposures which may significantly alter equilibrium have occurred prior to testing, all studies reported a statistically significant correlation between adipose tissue concentration and serum. Sex, pregnancy and occupational status appear to affect the partitioning ratios.
Additional research will be needed to understand the significance of observing different partition ratios. Metabolism of congeners may differ as does toxicity. The ratio of adipose to serum may become an important factor in understanding disease potential. The laboratory precision in both the adipose and serum analysis adds variability. Sample size plays an important role in influencing the stability of the regression equation.
It may be that these factors combined could explain the different ratios observed. These types of relationships are being actively explored. Utilizing adipose samples in conjunction with other biologic specimens adds an important dimension to our understanding.
Conclusion
Unless identification of low exposures is required, the close correlation between serum levels and adipose tissue residues suggests that once the correlation is characterized, blood samples may be the best choice for surveillance and monitoring for these types of chemicals (Table 4) . Whenever an adipose sample is obtained, unless from autopsy material, a serum specimen should also be included and paired results reported. The combination of these tissue analyses allows a better understanding of the dynamics and timing of an 
